Voloridge Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,574
| Closed | -$298K | – | 1149 |
|
|
2025
Q1 | $298K | Buy |
+35,574
| New | +$298K | ﹤0.01% | 1122 |
|
|
2024
Q1 | – | Sell |
-50,503
| Closed | -$307K | – | 1137 |
|
|
2023
Q4 | $307K | Buy |
+50,503
| New | +$307K | ﹤0.01% | 1079 |
|
|
2021
Q2 | – | Sell |
-57,822
| Closed | -$389K | – | 1593 |
|
|
2021
Q1 | $389K | Buy |
+57,822
| New | +$389K | ﹤0.01% | 1222 |
|
|
2020
Q2 | – | Sell |
-51,034
| Closed | -$178K | – | 1238 |
|
|
2020
Q1 | $178K | Buy |
+51,034
| New | +$178K | 0.01% | 973 |
|
|
2019
Q4 | – | Sell |
-85,825
| Closed | -$249K | – | 1067 |
|
|
2019
Q3 | $249K | Buy |
85,825
+2,453
| +3% | +$7.12K | ﹤0.01% | 968 |
|
|
2019
Q2 | $598K | Buy |
+83,372
| New | +$598K | 0.02% | 537 |
|